163 related articles for article (PubMed ID: 33415167)
1. Systematic Analysis of the Expression and Prognostic Significance of P4HA1 in Pancreatic Cancer and Construction of a lncRNA-miRNA-P4HA1 Regulatory Axis.
Hu Z; Song F; Hu Y; Liao T
Biomed Res Int; 2020; 2020():8877334. PubMed ID: 33415167
[TBL] [Abstract][Full Text] [Related]
2. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
[TBL] [Abstract][Full Text] [Related]
3. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
Li Q; Shen Z; Wu Z; Shen Y; Deng H; Zhou C; Liu H
J Clin Lab Anal; 2020 Mar; 34(3):e23107. PubMed ID: 31782831
[TBL] [Abstract][Full Text] [Related]
4. P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer.
Cao XP; Cao Y; Li WJ; Zhang HH; Zhu ZM
Biochem Biophys Res Commun; 2019 Aug; 516(3):606-612. PubMed ID: 31239153
[TBL] [Abstract][Full Text] [Related]
5. Identification of Potential Diagnostic and Prognostic Values of
Li M; Wu F; Zheng Q; Wu Y; Wu Y
DNA Cell Biol; 2020 May; 39(5):909-917. PubMed ID: 32150689
[TBL] [Abstract][Full Text] [Related]
6. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.
Chakravarthi BV; Pathi SS; Goswami MT; Cieślik M; Zheng H; Nallasivam S; Arekapudi SR; Jing X; Siddiqui J; Athanikar J; Carskadon SL; Lonigro RJ; Kunju LP; Chinnaiyan AM; Palanisamy N; Varambally S
Oncotarget; 2014 Aug; 5(16):6654-69. PubMed ID: 25115393
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of P4HA1 Is Correlated with Poor Survival and Immune Infiltrates in Lung Adenocarcinoma.
Zhou H; He Y; Li L; Wu C; Hu G
Biomed Res Int; 2020; 2020():8024138. PubMed ID: 33299876
[TBL] [Abstract][Full Text] [Related]
8. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
[TBL] [Abstract][Full Text] [Related]
9. MiR-122 inhibits epithelial mesenchymal transition by regulating P4HA1 in ovarian cancer cells.
Duan Y; Dong Y; Dang R; Hu Z; Yang Y; Hu Y; Cheng J
Cell Biol Int; 2018 Nov; 42(11):1564-1574. PubMed ID: 30136751
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA LINC01503 Promotes Gastric Cardia Adenocarcinoma Progression via miR-133a-5p/VIM Axis and EMT Process.
Guo Y; Sun P; Guo W; Dong Z
Dig Dis Sci; 2021 Oct; 66(10):3391-3403. PubMed ID: 33200343
[TBL] [Abstract][Full Text] [Related]
11. Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls.
Eriksson J; Le Joncour V; Jahkola T; Juteau S; Laakkonen P; Saksela O; Hölttä E
Mol Oncol; 2020 Apr; 14(4):742-762. PubMed ID: 32053263
[TBL] [Abstract][Full Text] [Related]
12. P4HA1, transcriptionally activated by STAT1, promotes esophageal cancer progression.
Gou W; Yang Y; Shan Q; Xia S; Ma Y
Pathol Int; 2023 Apr; 73(4):147-158. PubMed ID: 36734588
[TBL] [Abstract][Full Text] [Related]
13. Prolyl 4-hydroxylase P4HA1 Mediates the Interplay Between Glucose Metabolism and Stemness in Pancreatic Cancer Cells.
Cao X; Cao Y; Zhao H; Wang P; Zhu Z
Curr Stem Cell Res Ther; 2023; 18(5):712-719. PubMed ID: 36043766
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer.
Liu Q; Zhao H; Guo Y; Zhang K; Shang F; Liu T
J Healthc Eng; 2022; 2022():7904982. PubMed ID: 36105715
[TBL] [Abstract][Full Text] [Related]
16.
Sato K; Sano D; Takahashi H; Kuwahara T; Aizawa Y; Aoyama J; Nojima Y; Hatano T; Arai Y; Nishimura G; Hatakeyama H; Oridate N
Anticancer Res; 2023 Jun; 43(6):2571-2582. PubMed ID: 37247900
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
18. Construction of a novel mRNA-miRNA-lncRNA network and identification of potential regulatory axis associated with prognosis in colorectal cancer liver metastases.
Lu C; Luo X; Xing C; Mao Y; Xu Y; Gao W; Wang W; Zhan T; Wang G; Liu Z; Yu C
Aging (Albany NY); 2021 Jun; 13(11):14968-14988. PubMed ID: 34081622
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122.
Hu X; Zhang L; Tian J; Ma J
World J Surg Oncol; 2021 Apr; 19(1):122. PubMed ID: 33865422
[TBL] [Abstract][Full Text] [Related]
20. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
